ID

14401

Descripción

Effect of Inhaled Ciclesonide in Adult Patients With Asthma (BY9010/M1-125); ODM derived from: https://clinicaltrials.gov/show/NCT00546520

Link

https://clinicaltrials.gov/show/NCT00546520

Palabras clave

Versiones (1)
  1. 13/4/16 13/4/16 -
Titular de derechos de autor

CC BY-NC 3.0

Subido en

13 de abril de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Asthma NCT00546520

Inglés

Eligibility Asthma NCT00546520

1 formularios  
  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00546520
Criteria
Descripción

Criteria

out-patients
Descripción

outpatients

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0029921
written informed consent
Descripción

written informed consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
history of atopic disease
Descripción

atopy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0392707
history of perennial bronchial asthma for at least 6 months as defined by ats criteria
Descripción

perennial asthma

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0004096
UMLS CUI [1,2]
C0040223
current use of only inhaled short acting beta-2-agonist as required (for at least 4 weeks prior to baseline period b0)
Descripción

short acting beta-2-agonist

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2936789
stable asthma, i.e. no exacerbation or relevant respiratory tract infection within 2 months prior to study start
Descripción

stable asthma

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0004096
UMLS CUI [1,2]
C0205360
fev1 ≥ 70% predicted
Descripción

fev1

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0748133
hyperreactivity to amp (pc20fev1 < 25 mg/ml)
Descripción

hyperreactivity to amp

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0020517
good health with the exception of asthma
Descripción

good health with the exception of asthma

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0018759
UMLS CUI [1,2]
C0205170
UMLS CUI [2]
C0004096
non-smokers as well as ex-smokers with either = 10 pack-years or more than 6 months of smoking abstinence
Descripción

smoking history

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1519384
UMLS CUI [2]
C1277691
UMLS CUI [3]
C0337672
main exclusion criteria:
Descripción

exclusion criteria

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0680251
concomitant severe diseases or diseases which are contraindications for the use of inhaled steroids (e.g. lung tuberculosis)
Descripción

comorbidity limiting use of inhaled steroids

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0586793
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0009488
clinically relevant abnormal laboratory values suggesting an unknown disease and requiring further clinical evaluation
Descripción

abnormal laboratory values

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1254595
UMLS CUI [1,2]
C0009488
use of systemic steroids 4 weeks (injectable depot steroids 6 weeks) before entry into the baseline period, or more than 3 times during the last 6 months
Descripción

systemic steroids

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2825233
UMLS CUI [1,2]
C0040223
pregnancy or intention to become pregnant during the course of the study, breast feeding, lack of safe contraception in heterosexually active female patients of child-bearing potential, or postmenopausal for less than one year
Descripción

pregnancy or intention to become pregnant or lactation or lack of safe contraception

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2,1]
C0032961
UMLS CUI [2,2]
C1283828
UMLS CUI [3,1]
C0700589
UMLS CUI [3,2]
C0332197
UMLS CUI [4]
C0006147
UMLS CUI [5]
C3831118
UMLS CUI [6]
C0232970
copd (i.e. chronic bronchitis or emphysema) and/or other relevant lung diseases
Descripción

copd or other relevant lung diseases

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0024117
UMLS CUI [2]
C0024115
known or suspected hypersensitivity to inhaled steroids or to the other excipients of the metered dose inhalers
Descripción

hypersensitivity to inhaled steroids

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C2065041
immunotherapy within one month prior to b0 and/or during the entire study duration
Descripción

immunotherapy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0021083
UMLS CUI [1,2]
C0040223
Volver a la parte superior de la página

Similar models

Eligibility Asthma NCT00546520

1 formularios
  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00546520
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
outpatients
Item
out-patients
boolean
C0029921 (UMLS CUI [1])
written informed consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
atopy
Item
history of atopic disease
boolean
C0392707 (UMLS CUI [1])
perennial asthma
Item
history of perennial bronchial asthma for at least 6 months as defined by ats criteria
boolean
C0004096 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
short acting beta-2-agonist
Item
current use of only inhaled short acting beta-2-agonist as required (for at least 4 weeks prior to baseline period b0)
boolean
C2936789 (UMLS CUI [1])
stable asthma
Item
stable asthma, i.e. no exacerbation or relevant respiratory tract infection within 2 months prior to study start
boolean
C0004096 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
fev1
Item
fev1 ≥ 70% predicted
boolean
C0748133 (UMLS CUI [1])
hyperreactivity to amp
Item
hyperreactivity to amp (pc20fev1 < 25 mg/ml)
boolean
C0020517 (UMLS CUI [1])
good health with the exception of asthma
Item
good health with the exception of asthma
boolean
C0018759 (UMLS CUI [1,1])
C0205170 (UMLS CUI [1,2])
C0004096 (UMLS CUI [2])
smoking history
Item
non-smokers as well as ex-smokers with either = 10 pack-years or more than 6 months of smoking abstinence
boolean
C1519384 (UMLS CUI [1])
C1277691 (UMLS CUI [2])
C0337672 (UMLS CUI [3])
exclusion criteria
Item
main exclusion criteria:
boolean
C0680251 (UMLS CUI [1])
comorbidity limiting use of inhaled steroids
Item
concomitant severe diseases or diseases which are contraindications for the use of inhaled steroids (e.g. lung tuberculosis)
boolean
C0586793 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
abnormal laboratory values
Item
clinically relevant abnormal laboratory values suggesting an unknown disease and requiring further clinical evaluation
boolean
C1254595 (UMLS CUI [1,1])
C0009488 (UMLS CUI [1,2])
systemic steroids
Item
use of systemic steroids 4 weeks (injectable depot steroids 6 weeks) before entry into the baseline period, or more than 3 times during the last 6 months
boolean
C2825233 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
pregnancy or intention to become pregnant or lactation or lack of safe contraception
Item
pregnancy or intention to become pregnant during the course of the study, breast feeding, lack of safe contraception in heterosexually active female patients of child-bearing potential, or postmenopausal for less than one year
boolean
C0032961 (UMLS CUI [1])
C0032961 (UMLS CUI [2,1])
C1283828 (UMLS CUI [2,2])
C0700589 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C0006147 (UMLS CUI [4])
C3831118 (UMLS CUI [5])
C0232970 (UMLS CUI [6])
copd or other relevant lung diseases
Item
copd (i.e. chronic bronchitis or emphysema) and/or other relevant lung diseases
boolean
C0024117 (UMLS CUI [1])
C0024115 (UMLS CUI [2])
hypersensitivity to inhaled steroids
Item
known or suspected hypersensitivity to inhaled steroids or to the other excipients of the metered dose inhalers
boolean
C0020517 (UMLS CUI [1,1])
C2065041 (UMLS CUI [1,2])
immunotherapy
Item
immunotherapy within one month prior to b0 and/or during the entire study duration
boolean
C0021083 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial